Table 2.
Gene | mTNF-α | hIL-1β | hTNF-α |
---|---|---|---|
Prosurvival | |||
Survivin | 0.9 ± 0.6 | 1.1 ± 0.8 | 0.6 ± 0.3* |
Bcl-xL | 2.3 ± 0.9* | 1.9 ± 0.7 | 1.9 ± 0.6* |
c-FLIP | 2.3 ± 0.5** | 2.0 ± 0.3** | 3.3 ± 2.0 |
TRAF-2 | 3.5 ± 0.8** | 3.8 ± 1.0** | 2.9 ± 0.3 |
c-IAP1 | 6.2 ± 0.9** | 3.9 ± 0.6* | 7.3 ± 4.1 |
c-IAP2 | 12.2 ± 2.5** | 6.8 ± 1.9* | 17.8 ± 3.3** |
TRAF-1 | 57.0 ± 42.9* | 15.1 ± 17.1 | 120.2 ± 47.5* |
Antisurvival | |||
Bad | 1.9 ± 0.4* | 2.2 ± 1.0 | 2.2 ± 1.6 |
Bax | 1.5 ± 0.2** | 1.5 ± 0.2** | 1.2 ± 0.6** |
Bik | 1.6 ± 0.6** | 1.2 ± 0.2** | 2.7 ± 1.8 |
Bak-1 | 3.7 ± 1.0* | 2.7 ± 1.2* | 4.7 ± 2.0* |
Bid | 9.1 ± 1.2** | 3.1 ± 0.9** | 13.4 ± 4.0** |
Pooled mRPE cells were treated with either medium alone (basal), m- or hTNF-α (22 ng/mL), or hIL-1β (5 U/mL) in serum-free DMEM for 24 hours. RNA was extracted and reverse transcribed to synthesize cDNA. The transcripts were amplified using gene-specific primer pairs and quantified using qRT-PCR. Numbers correspond to the fold-difference between cytokine-treated gene expression and basal gene expression, after normalization to the reference gene, PPIA.
Data are the mean ± SD of three independent experiments.
P < 0.05 vs. untreated cells;
P < 0.005 vs. untreated cells.